These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 11500333)

  • 1. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.
    Kanner RE; Anthonisen NR; Connett JE;
    Am J Respir Crit Care Med; 2001 Aug; 164(3):358-64. PubMed ID: 11500333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking reduction and the rate of decline in FEV(1): results from the Lung Health Study.
    Simmons MS; Connett JE; Nides MA; Lindgren PG; Kleerup EC; Murray RP; Bjornson WM; Tashkin DP
    Eur Respir J; 2005 Jun; 25(6):1011-7. PubMed ID: 15929955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study.
    Kanner RE; Connett JE; Williams DE; Buist AS
    Am J Med; 1999 Apr; 106(4):410-6. PubMed ID: 10225243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study.
    Scanlon PD; Connett JE; Waller LA; Altose MD; Bailey WC; Buist AS; Tashkin DP;
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):381-90. PubMed ID: 10673175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
    Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N
    Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study.
    Garcia-Aymerich J; Lange P; Benet M; Schnohr P; Antó JM
    Am J Respir Crit Care Med; 2007 Mar; 175(5):458-63. PubMed ID: 17158282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Smoking cessation in patients with severe irreversible chronic obstructive pulmonary disease, "smoker's lung"].
    Johansen DL; Larsen V; Langfrits U; Døssing M
    Ugeskr Laeger; 1999 Jun; 161(24):3655-8. PubMed ID: 10485223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group.
    Tashkin DP; Altose MD; Connett JE; Kanner RE; Lee WW; Wise RA
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1802-11. PubMed ID: 8665038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of dopamine-related gene alleles, smoking behavior and decline in FEV1 in subjects with COPD: findings from the lung health study.
    Tashkin DP; Rabinoff M; Noble EP; Ritchie TL; Simmons MS; Connett J
    COPD; 2012 Dec; 9(6):620-8. PubMed ID: 22958175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function, and chronic obstructive pulmonary disease in smokers.
    Baekvad-Hansen M; Dahl M; Tybjaerg-Hansen A; Nordestgaard BG
    Am J Respir Crit Care Med; 2010 Jan; 181(1):17-20. PubMed ID: 19833825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis.
    Gamble E; Grootendorst DC; Hattotuwa K; O'Shaughnessy T; Ram FS; Qiu Y; Zhu J; Vignola AM; Kroegel C; Morell F; Pavord ID; Rabe KF; Jeffery PK; Barnes NC
    Eur Respir J; 2007 Sep; 30(3):467-71. PubMed ID: 17504799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking and lung function of Lung Health Study participants after 11 years.
    Anthonisen NR; Connett JE; Murray RP
    Am J Respir Crit Care Med; 2002 Sep; 166(5):675-9. PubMed ID: 12204864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of statins and lung function in current and former smokers.
    Keddissi JI; Younis WG; Chbeir EA; Daher NN; Dernaika TA; Kinasewitz GT
    Chest; 2007 Dec; 132(6):1764-71. PubMed ID: 17908708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease.
    Drummond MB; Hansel NN; Connett JE; Scanlon PD; Tashkin DP; Wise RA
    Am J Respir Crit Care Med; 2012 Jun; 185(12):1301-6. PubMed ID: 22561963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?
    Medbø A; Melbye H
    Respir Med; 2007 Jun; 101(6):1097-105. PubMed ID: 17239575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In long-term smokers and former smokers the bronchodilator response is not related to the fall in FEV.
    Stănescu D; Veriter C; Sanna A
    Respiration; 1999; 66(6):501-5. PubMed ID: 10575334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients.
    Tashkin DP; Rennard S; Taylor Hays J; Lawrence D; Marton JP; Lee TC
    Respir Med; 2011 Nov; 105(11):1682-90. PubMed ID: 21621992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Success of smoking cessation in patients with chronic obstructive pulmonary disease].
    Aytemur Solak Z; Başoğlu OK; Erdinç E
    Tuberk Toraks; 2006; 54(1):43-50. PubMed ID: 16615017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The UCLA population studies of chronic obstructive respiratory disease. VIII. Effects of smoking cessation on lung function: a prospective study of a free-living population.
    Tashkin DP; Clark VA; Coulson AH; Simmons M; Bourque LB; Reems C; Detels R; Sayre JW; Rokaw SN
    Am Rev Respir Dis; 1984 Nov; 130(5):707-15. PubMed ID: 6497153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of pulmonary function and COPD mortality in the multiple risk factor intervention trial.
    Kuller LH; Ockene JK; Townsend M; Browner W; Meilahn E; Wentworth DN
    Am Rev Respir Dis; 1989 Sep; 140(3 Pt 2):S76-81. PubMed ID: 2782764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.